Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Ciclopirox

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44343   clinical trials with a EudraCT protocol, of which   7372   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    20 result(s) found for: Ciclopirox. Displaying page 1 of 1.
    EudraCT Number: 2005-005897-54 Sponsor Protocol Number: S241-GB-08 Start Date*: 2006-02-01
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd
    Full Title: A Phase 1, Single-Centre, Single-blind, CPO Solution Human Patch Test in Healthy Subjects
    Medical condition: Not Applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005916-26 Sponsor Protocol Number: S241-GB-09 Start Date*: 2006-02-01
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd
    Full Title: A phase I, single-blind, CPO solution human repeat insult patch test in healthy subjects.
    Medical condition: Not Applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-004829-97 Sponsor Protocol Number: S241-GB-01 Start Date*: 2005-01-05
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel International R&D)
    Full Title: 96 HOUR HUMAN PATCH TEST FOR ASSESSMENT OF PRIMARY SKIN IRRITATION
    Medical condition: Not Applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005905-51 Sponsor Protocol Number: W0003-01 Start Date*: 2006-02-20
    Sponsor Name:Stiefel Laboratories (Maidenhead) Limited trading as Stiefel International Research and Development
    Full Title: A PHASE II, SINGLE CENTRE, RANDOMISED, PARALLEL GROUP, CLINICAL STUDY TO INVESTIGATE THE TOLERABILITY OF DOUBLE BLIND CICLOPIROX NAIL PRODUCT COMPARED TO DOUBLE BLIND PLACEBO NAIL PRODUCT COMPARED ...
    Medical condition: Mild to moderate onychomycosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed)
    Trial results: (No results available)
    EudraCT Number: 2022-003913-12 Sponsor Protocol Number: 22/589-EC_M. Start Date*: 2023-03-07
    Sponsor Name:COMPLUTENSE UNIVERSITY OF MADRID
    Full Title: Diode laser and photodynamic therapy Versus Ciclopirox Hydroxypropyl Chitosan. Randomised controlled clinical trial.
    Medical condition: Onychomycosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-004830-15 Sponsor Protocol Number: S241-GB-02 Start Date*: 2005-01-31
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel International R&D)
    Full Title: Human Repeat Insult Patch Test with Challenge
    Medical condition: Not Applicable (Healthy Volunteer Study)
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-003087-70 Sponsor Protocol Number: PM1125 Start Date*: 2011-12-02
    Sponsor Name:Polichem SA
    Full Title: Randomized, open-label, controlled study on the efficacy of Ciclopoli® (ciclopirox 8% nail lacquer) versus Loceryl® (amorolfine 5% nail lacquer) on the culture conversion to negative in patients w...
    Medical condition: distal subungual onychomycosis without lunula involvement due to fungal nail pathogens (dermatophytes, white yeasts and/or Scopulariopsis spp. and/or Fusarium spp.) affecting at least one big toenail
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2018-001633-41 Sponsor Protocol Number: 18-01/Cic-C Start Date*: 2019-06-18
    Sponsor Name:Dermapharm AG
    Full Title: Double-blind, randomised clinical study comparing efficacy and safety of Ciclopirox Olamine Cream 10 mg/g (Test) vs. Batrafen® Cream (Reference) vs. Vehicle in patients with skin mycoses
    Medical condition: dermatomycoses
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10012502 Dermatomycosis, unspecified LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-001371-35 Sponsor Protocol Number: S241-GB-03 Start Date*: 2005-05-18
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel Laboratories International Division)
    Full Title: A Double-Blind, Placebo Controlled, Half-Head Design, CPO Solution Dose Ranging-Finding Study in Patients with Seborrhoeic Dermatitis of the Scalp
    Medical condition: Seborrhoeic dermatitis
    Disease: Version SOC Term Classification Code Term Level
    8.0 10039793 LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-000292-15 Sponsor Protocol Number: S241-GB-10 Start Date*: 2006-03-13
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd.
    Full Title: A Phase II, Single-Centre, Randomised,Double-Blind, Parallel Group, CPO Solution, Dose Range Finding Study in Subjects with Seborrhoeic Dermatitis of the Scalp
    Medical condition: Seborrhoeic dermatitis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039793 Seborrhoeic dermatitis LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-005895-42 Sponsor Protocol Number: TLT-CLI-001 Start Date*: 2009-03-02
    Sponsor Name:TLT Medical Ltd.
    Full Title: A study to determine the safety and efficacy of a terbinafine topical formulation system in subjects with onychomycosis in laser treated toenails versus ciclopirox lacquer in intact toenails
    Medical condition: Distal/lateral Subungual onychomycosis (DSO) caused by dermatophytes
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-000720-19 Sponsor Protocol Number: IDI01/2020 Start Date*: 2020-07-22
    Sponsor Name:IDI FARMACEUTICI SRL
    Full Title: A prospective, randomized, multicenter, open- label, two-arm and parallel-group Study to evaluate the efficacy and safety of Nicotinamide DS compared to Ciclopirox olamine cream at 1% in patients a...
    Medical condition: Patients affected by seborrheic dermatitis.
    Disease: Version SOC Term Classification Code Term Level
    21.1 10040785 - Skin and subcutaneous tissue disorders 10039793 Seborrhoeic dermatitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-003560-19 Sponsor Protocol Number: CPO-08-01 Start Date*: 2008-10-17
    Sponsor Name:Laboratorios Novag S.A.
    Full Title: "Estudio para la evaluación de la seguridad y la eficacia de la crema de ciclopirox olamina en niños de 3 meses a 10 años afectos de dermatomicosis". "Study for safety and efficacy evaluation of c...
    Medical condition: Dermatomicosis de la piel lampiña originada por levaduras y/o dermatofitos
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-022861-93 Sponsor Protocol Number: 201003.2.45 Start Date*: 2010-10-28
    Sponsor Name:Laboratoire LABCATAL
    Full Title: Confirmation de l'efficacité et de la tolérance du LBC 45 dans la dermite séborrhéique du cuir chevelu
    Medical condition: Dermite séborrhéique du cuir chevelu
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039788 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-002471-32 Sponsor Protocol Number: S173-GB-01 Start Date*: Information not available in EudraCT
    Sponsor Name:Stiefel Laboratories Maidenhead Ltd (commonly known as Stiefel International R&D)
    Full Title: A PHASE II, SINGLE-CENTRE, INVESTIGATOR-BLIND, PARALLEL GROUP CLINICAL TRIAL TO INVESTIGATE THE EFFICACY AND SAFETY OF 1% CICLOPIROX OLAMINE (BATRAFEN® CREAM), COMPARED TO 1% HYDROCORTISONE ACETATE...
    Medical condition: Mild to moderate atopic eczema
    Disease: Version SOC Term Classification Code Term Level
    8.0 10003641 LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2009-011125-14 Sponsor Protocol Number: RV4104A-2008-548 Start Date*: 2009-07-06
    Sponsor Name:Pierre Fabre Dermatologie
    Full Title: A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solutio...
    Medical condition: Patients suffering from distal-lateral or lateral subungual onychomycosis of one great toenail (the target nail) without matrix involvement
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2016-003784-19 Sponsor Protocol Number: RJ-CPX01 Start Date*: 2017-07-21
    Sponsor Name:Laboratorio Reig Jofre, SA
    Full Title: Phase III, multicentre, randomised, double blind, parallel-group, clinical trial to evaluate the efficacy and safety of a new medicated nail lacquer for the treatment of toenail fungal infection
    Medical condition: toenail onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    19.1 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) LV (Completed)
    Trial results: View results
    EudraCT Number: 2008-008353-35 Sponsor Protocol Number: DC0115GM2012A Start Date*: 2009-03-18
    Sponsor Name:PIERRE FABRE DERMATOLOGIE REPRESENTED BY INSTITUT DE RECHERCHE PIERRE FABRE
    Full Title: EFFICACY STUDY OF A CICLOPIROXOLAMINE 1% FOAM (DC115 GM 02A) VERSUS CICLOPIROXOLAMINE 1.5% SHAMPOO (SEBIPROX®) IN THE TREATMENT OF MODERATE SEBORRHEIC DERMATITIS OF THE SCALP
    Medical condition: Topical treatment of moderate seborrheic dermatitis of the scalp
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039788 Seborrheic dermatitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2015-001237-24 Sponsor Protocol Number: RD.03.SPR.105082 Start Date*: 2015-07-28
    Sponsor Name:Galderma R&D
    Full Title: Subject adherence and satisfaction for treatment of Onychomycosis with Loceryl® Nail Lacquer 5% versus Ciclopoli® Nail Lacquer.
    Medical condition: Toenail Distal and Lateral Subungual Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    18.0 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-001204-39 Sponsor Protocol Number: MOB015B-III Start Date*: 2016-09-15
    Sponsor Name:Moberg Pharma AB (publ)
    Full Title: A multi-centre, randomized, two-armed, parallel group and evaluator-blinded study of efficacy and safety of topical MOB015B in the treatment of mild to moderate distal subungual onychomycosis (DSO)
    Medical condition: Distal Subungual Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) PL (Completed) GB (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Jun 16 01:50:57 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA